Skip to main content
. 2025 May 28;84:103256. doi: 10.1016/j.eclinm.2025.103256

Table 6.

Percentage of participants per subgroup giving a “yes” response (score of 3 for relevance or comprehensiveness or 2 for ease of understanding).

CAR T-cell therapy patients (%) Healthcare professionals/researchers (%)
Relevance 58 67
Comprehensiveness 69 66
Ease of Understanding 67 74